Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity

Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of hematology 2009-10, Vol.90 (3), p.374-377
Hauptverfasser: Ando, Toshihiko, Mitani, Noriyuki, Matsui, Kumiko, Yamashita, Koji, Nomiyama, Jun, Tsuru, Masatoshi, Yujiri, Toshiaki, Tanizawa, Yukio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 377
container_issue 3
container_start_page 374
container_title International journal of hematology
container_volume 90
creator Ando, Toshihiko
Mitani, Noriyuki
Matsui, Kumiko
Yamashita, Koji
Nomiyama, Jun
Tsuru, Masatoshi
Yujiri, Toshiaki
Tanizawa, Yukio
description Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.
doi_str_mv 10.1007/s12185-009-0385-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745902995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745729055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</originalsourceid><addsrcrecordid>eNqNkl2L1TAQhoso7rr6A7yRIIh6Uc1H06R4JcdPWBBEr8s0ne7JmibdJFXPz_OfmeM5uCAIC4FMmCfvZDJvVT1k9AWjVL1MjDMta0q7mooSiFvVKdNtCZRqblentOOylorRk-peSpeUMkUbdbc6YV3L9-u0-vUZzRoj-kzwZ44w47g6B3FHIjpYEpIwETBrRjLv0IUL9GFNxOH6DWcLBKaMkYD7k0FryBZnyGEJFnM5pYwzMegcKdo-LQ58hmyDJ9YTIEuJ96V_2LwleYvEbGOYQwozOAKDD7EENu9IfqZfcfacgB_J5o1s6yUkm-33krtf3ZnAJXxw3M-qr-_eftl8qM8_vf-4eX1eG9l0uVYMR9G0VLNOimlscQRQohVat62UoxhAm4kZMw7SAKIaAMAIOekBO9o0XJxVTw-6SwxXK6bczzbtWwOP5Ut61ciO8q6o34BUvKPyZiQVXHeFfPwPeRnW6EvDPWdKaKa1LhA7QCaGlCJO_RLtXIbZM9rvHdMfHNMXx_R7x_Si3Hl0FF6HMvzrG0eLFODJEYBkwE1ljsamvxznnBa5pnD8wKWS8hcYr1_4_-q_ARKv3N0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217381888</pqid></control><display><type>article</type><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</creator><creatorcontrib>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</creatorcontrib><description>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-009-0385-3</identifier><identifier>PMID: 19629629</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Biological and medical sciences ; Case Report ; CD56 Antigen - metabolism ; Chromosome aberrations ; Chromosomes, Human, Pair 21 ; Chromosomes, Human, Pair 8 ; Gastric Mucosa - pathology ; Graft vs Leukemia Effect ; Hematologic and hematopoietic diseases ; Hematology ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute - genetics ; Leukemia, Myeloid, Acute - pathology ; Leukemia, Myeloid, Acute - therapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical genetics ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Oncology ; Recurrence ; Stomach Neoplasms - genetics ; Stomach Neoplasms - pathology ; Stomach Neoplasms - therapy ; Translocation, Genetic ; Transplantation, Homologous ; Young Adult</subject><ispartof>International journal of hematology, 2009-10, Vol.90 (3), p.374-377</ispartof><rights>The Japanese Society of Hematology 2009</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</citedby><cites>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-009-0385-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-009-0385-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22200094$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19629629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ando, Toshihiko</creatorcontrib><creatorcontrib>Mitani, Noriyuki</creatorcontrib><creatorcontrib>Matsui, Kumiko</creatorcontrib><creatorcontrib>Yamashita, Koji</creatorcontrib><creatorcontrib>Nomiyama, Jun</creatorcontrib><creatorcontrib>Tsuru, Masatoshi</creatorcontrib><creatorcontrib>Yujiri, Toshiaki</creatorcontrib><creatorcontrib>Tanizawa, Yukio</creatorcontrib><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</description><subject>Biological and medical sciences</subject><subject>Case Report</subject><subject>CD56 Antigen - metabolism</subject><subject>Chromosome aberrations</subject><subject>Chromosomes, Human, Pair 21</subject><subject>Chromosomes, Human, Pair 8</subject><subject>Gastric Mucosa - pathology</subject><subject>Graft vs Leukemia Effect</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>Leukemia, Myeloid, Acute - therapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Recurrence</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - therapy</subject><subject>Translocation, Genetic</subject><subject>Transplantation, Homologous</subject><subject>Young Adult</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkl2L1TAQhoso7rr6A7yRIIh6Uc1H06R4JcdPWBBEr8s0ne7JmibdJFXPz_OfmeM5uCAIC4FMmCfvZDJvVT1k9AWjVL1MjDMta0q7mooSiFvVKdNtCZRqblentOOylorRk-peSpeUMkUbdbc6YV3L9-u0-vUZzRoj-kzwZ44w47g6B3FHIjpYEpIwETBrRjLv0IUL9GFNxOH6DWcLBKaMkYD7k0FryBZnyGEJFnM5pYwzMegcKdo-LQ58hmyDJ9YTIEuJ96V_2LwleYvEbGOYQwozOAKDD7EENu9IfqZfcfacgB_J5o1s6yUkm-33krtf3ZnAJXxw3M-qr-_eftl8qM8_vf-4eX1eG9l0uVYMR9G0VLNOimlscQRQohVat62UoxhAm4kZMw7SAKIaAMAIOekBO9o0XJxVTw-6SwxXK6bczzbtWwOP5Ut61ciO8q6o34BUvKPyZiQVXHeFfPwPeRnW6EvDPWdKaKa1LhA7QCaGlCJO_RLtXIbZM9rvHdMfHNMXx_R7x_Si3Hl0FF6HMvzrG0eLFODJEYBkwE1ljsamvxznnBa5pnD8wKWS8hcYr1_4_-q_ARKv3N0</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Ando, Toshihiko</creator><creator>Mitani, Noriyuki</creator><creator>Matsui, Kumiko</creator><creator>Yamashita, Koji</creator><creator>Nomiyama, Jun</creator><creator>Tsuru, Masatoshi</creator><creator>Yujiri, Toshiaki</creator><creator>Tanizawa, Yukio</creator><general>Springer Japan</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20091001</creationdate><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><author>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Case Report</topic><topic>CD56 Antigen - metabolism</topic><topic>Chromosome aberrations</topic><topic>Chromosomes, Human, Pair 21</topic><topic>Chromosomes, Human, Pair 8</topic><topic>Gastric Mucosa - pathology</topic><topic>Graft vs Leukemia Effect</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>Leukemia, Myeloid, Acute - therapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Recurrence</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - therapy</topic><topic>Translocation, Genetic</topic><topic>Transplantation, Homologous</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ando, Toshihiko</creatorcontrib><creatorcontrib>Mitani, Noriyuki</creatorcontrib><creatorcontrib>Matsui, Kumiko</creatorcontrib><creatorcontrib>Yamashita, Koji</creatorcontrib><creatorcontrib>Nomiyama, Jun</creatorcontrib><creatorcontrib>Tsuru, Masatoshi</creatorcontrib><creatorcontrib>Yujiri, Toshiaki</creatorcontrib><creatorcontrib>Tanizawa, Yukio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ando, Toshihiko</au><au>Mitani, Noriyuki</au><au>Matsui, Kumiko</au><au>Yamashita, Koji</au><au>Nomiyama, Jun</au><au>Tsuru, Masatoshi</au><au>Yujiri, Toshiaki</au><au>Tanizawa, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>90</volume><issue>3</issue><spage>374</spage><epage>377</epage><pages>374-377</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>19629629</pmid><doi>10.1007/s12185-009-0385-3</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0925-5710
ispartof International journal of hematology, 2009-10, Vol.90 (3), p.374-377
issn 0925-5710
1865-3774
language eng
recordid cdi_proquest_miscellaneous_745902995
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Biological and medical sciences
Case Report
CD56 Antigen - metabolism
Chromosome aberrations
Chromosomes, Human, Pair 21
Chromosomes, Human, Pair 8
Gastric Mucosa - pathology
Graft vs Leukemia Effect
Hematologic and hematopoietic diseases
Hematology
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - pathology
Leukemia, Myeloid, Acute - therapy
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical genetics
Medical sciences
Medicine
Medicine & Public Health
Oncology
Recurrence
Stomach Neoplasms - genetics
Stomach Neoplasms - pathology
Stomach Neoplasms - therapy
Translocation, Genetic
Transplantation, Homologous
Young Adult
title Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A54%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20extramedullary%20relapse%20of%20acute%20myelogenous%20leukemia%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20in%20a%20patient%20with%20the%20chromosomal%20abnormality%20t(8;21)%20and%20CD56-positivity&rft.jtitle=International%20journal%20of%20hematology&rft.au=Ando,%20Toshihiko&rft.date=2009-10-01&rft.volume=90&rft.issue=3&rft.spage=374&rft.epage=377&rft.pages=374-377&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-009-0385-3&rft_dat=%3Cproquest_cross%3E745729055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217381888&rft_id=info:pmid/19629629&rfr_iscdi=true